ARTICLE | Distillery Therapeutics
A low-density lipoprotein receptor identified as tauopathy target
May 1, 2020 6:11 PM UTC
INDICATION: Neurology...
BCIQ Company Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
INDICATION: Neurology...
BCIQ Company Profiles